CORDAVIS
Live / Registered — Registered (as of 11 Nov 2025)
What this means for you
Registered since 11 Nov 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97980606
- Registration number
- 8024186
- Mark type
- Stylized text
- Filed
- 19 Jan 2023
- Published for opposition
- 16 Jan 2024
- Registered
- 11 Nov 2025
- Attorney of record
- Kelly A. Donahue
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products, namely, prescription drugs and biological preparations for treating chronic diseases, respiratory diseases, arthritic diseases, for ophthalmological use, and for the prevention of high blood pressure; Pharmaceutical products, namely, generic prescription drugs for treating chronic diseases, respiratory diseases, arthritic diseases, for ophthalmological use, and for the prevention of high blood pressure
- Class 040 — Treatment of materials: Custom manufacture of pharmaceutical products; Custom manufacture of generic prescription drugs
Owner
- CORDAVIS LIMITED, DUBLIN, IE
- CORDAVIS LIMITED, DUBLIN, IE
- CORDAVIS LIMITED, DUBLIN, IE
- North 53 TAOH Limited, Dublin, IE
Prosecution history
- 11 Nov 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 11 Nov 2025 — REGISTERED-PRINCIPAL REGISTER
- 20 Oct 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 20 Oct 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 28 Aug 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 07 Feb 2025 — USE AMENDMENT FILED
- 28 Aug 2025 — DIVISIONAL PROCESSING COMPLETE
- 07 Feb 2025 — DIVISIONAL REQUEST RECEIVED
- 18 Apr 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 07 Feb 2025 — TEAS STATEMENT OF USE RECEIVED
- 07 Feb 2025 — TEAS REQUEST TO DIVIDE RECEIVED
- 20 Jun 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Jun 2024 — SOU EXTENSION 1 GRANTED
- 20 Jun 2024 — SOU EXTENSION 1 FILED
- 20 Jun 2024 — SOU TEAS EXTENSION RECEIVED